ClinicalTrials.Veeva

Menu

Assessment of Circulatory Compromise With Ox-Imager Using a Vascular Occlusion Test Protocol

M

Modulated Imaging

Status

Unknown

Conditions

Circulatory; Change

Treatments

Device: The Ox-Imager Mini (Desaturation)

Study type

Interventional

Funder types

Industry

Identifiers

NCT03563105
900-0003

Details and patient eligibility

About

The objective of this study is to evaluate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system to measure potential circulatory compromise.

Full description

The objective of this study is to demonstrate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system, "The Ox-Imager Mini". Potential circulatory compromise will be imaged in healthy volunteers using both the subject and predicate devices (Ox-Imager CS) in a Vascular Occlusion Test (VOT) model. The VOT model is an established paradigm to introduce transient ischemia in skin and the the subjects will be imaged during this time. The primary endpoint will be to measure significant decrease in tissue oxygen saturation after occlusion for both predicate and subject devices.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Over 18 years of age

Exclusion criteria

  • History of congestive heart failure
  • Patients with existing wound or ulcer.
  • Rheumatoid arthritis
  • Pregnant or lactating women

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Desaturation
Experimental group
Description:
Vascular Occlusion Test
Treatment:
Device: The Ox-Imager Mini (Desaturation)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems